ArticleCancer communications (London, England)2025
Epigenomic exploration of disease status of EGFR-mutated non-small cell lung cancer using plasma cell-free DNA hydroxymethylomes.
Yong Peng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.